2015 American Transplant Congress » Concurrent Session: Late Breaking

2:15pm-2:27pm

B-Cell Tolerance to Donor Alloantigens

A. Patil, M. Climov, A. Matar, A. Musa, E. Harrington, D. Sachs, R. Duran-Struuck, C. Huang.

2:27pm-2:39pm

ASKP1240 in De Novo Kidney Transplant Recipients

R. Harland,¹ G. Klintmalm,² H. Yang,³ S. Jensik,⁴ T. Shah,⁵ P. West-Thielke,⁶ F. Shihab,⁷ W. Zhang,⁸ V. Santos,⁸ R. Tainaka,⁸ X. Wang,⁸ R. First,⁸ J. Holman.⁸

2:39pm-2:51pm

Pre-Transplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Chronic Portal Vein Thrombosis

B. Thornburg, K. Desai, T. Baker, J. Fryer, M. Abecassis, J. Caicedo, L. Kulik, R. Salem.

2:51pm-3:03pm

AAV-Mediated TIMP-1 Gene Therapy Ameliorates Hepatic Ischemia/Reperfusion Injury

S. Duarte, T. Fujii, G. Lipshutz, R. Busuttil, A. Coito.

3:03pm-3:15pm

Interim Results of a Phase 1 Trial of Treg Adoptive Cell Transfer (TRACT) in Living Donor Kidney Transplant Recipients

J. Leventhal,¹ A. LeFever,² A. Skaro,¹ L. Gallon,¹ J. Mathew,¹ D. Stare,¹ I. Konieczna,¹ J. He,¹ G. Johnson.³

3:15pm-3:27pm

Treatment of Hepatitis C Virus in Kidney Transplant Recipients With Direct Acting Anti-Viral Agents: Early Results in 12 Cases

A. Sharfuddin,¹ T. Taber,¹ M. Mujtaba,¹ M. Yaqub,¹ D. Mishler,¹ P. Kwo,² R. Vuppalanchi.²

3:27pm-3:39pm

Eculizumab in Prevention of Acute Antibody-Mediated Rejection in Sensitized Deceased-Donor Kidney Transplant Recipients: 1-Year Outcomes

D. Glotz,¹ G. Russ,² L. Rostaing,³ C. Legendre,⁴ S. Chadban,⁵ J. Grinyo,⁶ N. Mamode,⁷ E. Cozzi,¹¹ Y. Lebranchu,⁸ S. Sandrini,⁹ L. Couzi,¹² W. Marks.¹⁰